康力龙治疗再生障碍性贫血的效果及其不良反应发生情况分析

Analysis of the Effect and Adverse Reaction of Stanozolol in Treatment of Aplastic Anemia

目的:分析探究康力龙治疗再生障碍性贫血的效果及其不良反应发生情况。方法:选取2016年1月-2017年1月本院收治的确诊为再生障碍性贫血的患者90例,按照随机数字表法分为研究组与对照组,每组45例。对照组接受环孢素A胶囊治疗,研究组接受康力龙治疗。比较两组患者的治疗效果以及不良反应的发生情况,比较两组治疗后1、3、6、9个月后复发情况。结果:研究组治疗总有效率明显高于对照组(P<0.05)。研究组不良反应发生率明显低于对照组(P<0.05)。接受治疗1、3、6个月后,两组复发率比较,差异均无统计学意义(P>0.05);接受治疗9个月后,研究组复发率低于对照组,差异有统计学意义(P<0.05)。结论:应用康力龙治疗再生障碍性贫血能够明显提高临床效果,降低患者的不良反应发生率和复发率,可行性程度较高,值得临床上推广应用。

Objective：To explore the analysis of Stanozolol in treatment of aplastic anemia and its effect on the occurrence of adverse reactions.Method：A total of 90 cases of aplastic anemia in our hospital from January 2016 to January 2017 were selected,they were divided into study group and control group according to table of random numbers,45 cases in each group.The control group was treated with Cyclosporin,the study group was treated with Stanozolol.The therapeutic effects,the adverse reactions,and the recurrence after treatment 1,3,6,9 months were compared between the two groups.Result：The treatment effective rate in the study group was significantly higher than that in the control group（P〈0.05）.The rate of adverse reactions in the study group was lower than that in the control group（P〈0.05）.There were no significant differences in recurrence rate between the two groups after treatment for 1,3,6 and 9 months（P〈0.05）.The recurrence rate after treatment 9 month in the study group was lower than that in the control group（P〈0.05）.Conclusion：The application of Stanozolol for aplastic anemia can significantly improve the effect,reduce the adverse reactions and recurrence rate,has high feasibility,it is worthy of popularization.